Aurobindo Pharma gets FDA nod for Sertraline Hydrochloride

MUMBAI, Nov 7 (Reuters) - Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) on Friday said it got final approval from the U.S. Food and Drug Administration to make and market a 20 mg dose of Sertraline Hydrochloride.

Sertraline is the generic equivalent of Pfizer's (PFE.N: Quote, Profile, Research) Zoloft used for the treatment of depressive disorder in adults.

(Reporting by Aniruddha Basu; Editing by Prem Udayabhanu)